Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, Gland Pharma has informed that it enclosed details of Investor Conference/ Event the Company plan to attend on 30th November 2021.
The above information is a part of company’s filings submitted to BSE.